Aptus Capital Advisors LLC increased its position in Amdocs Limited (NASDAQ:DOX – Free Report) by 15.1% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 62,331 shares of the technology company’s stock after acquiring an additional 8,169 shares during the quarter. Aptus Capital Advisors LLC owned about 0.06% of Amdocs worth $5,114,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Amundi increased its stake in shares of Amdocs by 73.0% in the first quarter. Amundi now owns 13,778 shares of the technology company’s stock worth $1,217,000 after purchasing an additional 5,816 shares in the last quarter. Millennium Management LLC lifted its stake in shares of Amdocs by 458.3% during the 1st quarter. Millennium Management LLC now owns 67,047 shares of the technology company’s stock valued at $6,135,000 after buying an additional 55,038 shares in the last quarter. Goldman Sachs Group Inc. boosted its holdings in Amdocs by 12.6% in the 1st quarter. Goldman Sachs Group Inc. now owns 331,146 shares of the technology company’s stock worth $30,300,000 after buying an additional 37,087 shares during the period. Empowered Funds LLC boosted its holdings in Amdocs by 12.0% in the 1st quarter. Empowered Funds LLC now owns 15,979 shares of the technology company’s stock worth $1,462,000 after buying an additional 1,709 shares during the period. Finally, Jane Street Group LLC increased its stake in Amdocs by 195.4% in the 1st quarter. Jane Street Group LLC now owns 115,929 shares of the technology company’s stock worth $10,608,000 after buying an additional 76,683 shares in the last quarter. Institutional investors own 92.02% of the company’s stock.
Wall Street Analysts Forecast Growth
A number of equities analysts have recently weighed in on the company. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Amdocs in a research note on Tuesday, January 27th. Wall Street Zen raised Amdocs from a “hold” rating to a “buy” rating in a research note on Saturday, February 7th. Barclays lowered their price target on Amdocs from $111.00 to $92.00 and set an “overweight” rating on the stock in a report on Wednesday, February 4th. Wolfe Research restated a “peer perform” rating on shares of Amdocs in a research note on Thursday, November 13th. Finally, Stifel Nicolaus reduced their price objective on shares of Amdocs from $97.00 to $88.00 and set a “buy” rating on the stock in a research report on Wednesday, February 4th. Three analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, Amdocs currently has an average rating of “Moderate Buy” and an average target price of $92.33.
Amdocs Trading Up 1.8%
Shares of Amdocs stock opened at $69.71 on Friday. Amdocs Limited has a twelve month low of $65.74 and a twelve month high of $95.41. The company has a quick ratio of 1.06, a current ratio of 1.06 and a debt-to-equity ratio of 0.23. The business has a 50-day moving average price of $76.40 and a 200-day moving average price of $79.87. The firm has a market cap of $7.53 billion, a price-to-earnings ratio of 13.48, a PEG ratio of 1.23 and a beta of 0.42.
Amdocs (NASDAQ:DOX – Get Free Report) last released its quarterly earnings data on Tuesday, February 3rd. The technology company reported $1.81 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.75 by $0.06. The business had revenue of $1.16 billion for the quarter, compared to the consensus estimate of $1.15 billion. Amdocs had a return on equity of 20.19% and a net margin of 12.47%.The company’s revenue was up 4.1% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.66 EPS. Amdocs has set its Q2 2026 guidance at 1.730-1.790 EPS and its FY 2026 guidance at 7.270-7.550 EPS. Equities research analysts anticipate that Amdocs Limited will post 6.21 EPS for the current fiscal year.
Amdocs Increases Dividend
The firm also recently declared a quarterly dividend, which will be paid on Friday, April 24th. Investors of record on Tuesday, March 31st will be given a $0.569 dividend. This is a boost from Amdocs’s previous quarterly dividend of $0.53. This represents a $2.28 annualized dividend and a yield of 3.3%. The ex-dividend date is Tuesday, March 31st. Amdocs’s dividend payout ratio (DPR) is presently 40.81%.
Amdocs Profile
Amdocs (NASDAQ: DOX) is a global software and services provider specializing in solutions for communications, media and entertainment companies. The company designs, develops and integrates revenue management, customer experience and digital services platforms that enable service providers to launch and monetize new offerings, streamline operations and enhance subscriber engagement. Amdocs’ product suite encompasses billing and order management, customer relationship management, digital commerce and network function virtualization, supported by professional services for implementation, integration and managed operations.
Founded in 1982 and structured as a separate public company in 1998, Amdocs has its corporate headquarters in Chesterfield, Missouri, and maintains major development centers in Ra’anana, Israel.
Further Reading
- Five stocks we like better than Amdocs
- “I just bought 10,000 shares of a $5 stock…”
- How JPMorgan’s $8,000 Gold Call Will Leave Most Retirement Accounts Behind
- Silver Is the New Oil—And the World’s Running Dry
- SpaceX IPO Confirmed: Claim Your Stake Today
- What central banks are doing with gold right now
Want to see what other hedge funds are holding DOX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amdocs Limited (NASDAQ:DOX – Free Report).
Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.
